Tasigna for chronic myeloid leukemiaIn October, Novartis expects to launch Tasigna for the treatment of chronic myeloid leukemia in adults who have developed resistance or intolerance to at least one prior therapy, including imatinib. Xarelto: new oral anticoagulantBayer's Xarelto (rivaroxaban 10 mg tablets) is the second new oral anticoagulant to be marketed in Canada this year, following the introduction of Boehringer Ingelheim's Pradax (dabigatran etexilate 75 mg and 110 mg capsules) in July. Insect repellents: new patient guidelines Liberals promise catastrophic drug plan New Listeria guidelines New Natural Health Products database now available New guidelines: bacterial vaginosis in pregnancy Awards predict top sellers Valcyte: new dosage form Study finds impact of drug advertising exaggerated First Previous 2314 2315 2316 2317 2318 Next Last
